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Adrenal glands and gonads share a common pri-
mordium (AGP), but the molecular events driving
differentiation are poorly understood. Here we
demonstrate that the Wilms tumor suppressor WT1
is a key factor defining AGP identity by inhibiting
the steroidogenic differentiation process. Indeed,
ectopic expression of WT1 precludes differentiation
into adrenocortical steroidogenic cells by locking
them into a progenitor state. Chromatin immunopre-
cipitation experiments identify Tcf21 and Gli1 as
direct targets of WT1. Moreover, cell lineage tracing
analyses identify a long-living progenitor population
within the adrenal gland, characterized by the
expression of WT1, GATA4, GLI1, and TCF21, that
can generate steroidogenic cells in vivo. Strikingly,
gonadectomy dramatically activates these WT1+
cells and leads to their differentiation into gonadal
steroidogenic tissue. Thus, our data describe a
mechanism of response to organ loss by recreating
hormone-producing cells at a heterotopic site.
INTRODUCTION
Adrenal glands and gonads are crucial steroidogenic organs
required to maintain body homeostasis in mammals. Consistent
with their overlapping functions, the adrenal cortex and gonads
share a common developmental origin, the adrenogonadal pri-
mordium (AGP). In the mouse, the AGP can be first detected
as a thickening of the coelomic epithelium at approximately em-
bryonic day (E) E9.5 (Hatano et al., 1996; Ikeda et al., 1994). By
E10.5, the AGP splits into adrenal and gonadal primordia that
will continue to differentiate along separate pathways. Neural
crest-derived cells invade the adrenal primordium at E12.5 and
will ultimately differentiate into the neuroendocrine chromaffin
cells (Anderson and Axel, 1986). Encapsulation of the adrenal
occurs at E14.5, in a process that is believed to involve conden-Desation of mesenchymal cells surrounding the developing organ
(Mesiano and Jaffe, 1997; Uotila, 1940). However, definitive
proof of this hypothesis is missing to date. After encapsulation,
adrenal development proceeds with development of the defini-
tive cortex (Zubair et al., 2008) followed by the formation of spe-
cific steroidogenic zones (glomerulosa, fasciculata, X-zone), a
process that is only completed after birth.
The Wilms tumor suppressor gene 1 (WT1) encodes a tran-
scriptional regulator that plays key roles during the formation
of many organs (Hohenstein and Hastie, 2006). More recent
work highlights an equally important role in the maintenance
and repair of several tissues (Chau et al., 2011; Smart et al.,
2011). The molecular biology of WT1 is complex and at least
36 different isoforms can be produced by a combination of alter-
native transcription start sites, alternative splicing, and RNA
editing. Alternative splicing at the junction of exons 9 and 10 gen-
erates distinct isoforms that contain (+KTS) or lack (KTS) the
three amino acids KTS, which gives rise to proteins that have
different biochemical and biological properties. WT1-KTS shows
high affinity to DNA (Bickmore et al., 1992) and a diffuse nuclear
distribution (Larsson et al., 1995) that is typical of classic tran-
scription factors. Indeed, several studies have demonstrated
the ability of WT1-KTS to directly regulate gene expression
(Hohenstein and Hastie, 2006) and influence the chromatin state
of target loci (Essafi et al., 2011). In contrast, WT1 +KTS isoforms
preferentially bind RNA (Caricasole et al., 1996; Kennedy et al.,
1996) and have been suggested to play a role in RNAmetabolism
(Niksic et al., 2004). In vivo evidence for distinct roles of +KTS
and KTS comes from genetic analysis in mice and mutants
lacking either of the variants display distinct phenotypes
(Hammes et al., 2001).
Development of the AGP requires WT1 and its direct target
SF1 (Luo et al., 1994; Val et al., 2007; Wilhelm and Englert,
2002) and targeted deletion of either of these genes results in
AGP apoptosis and, as a consequence, agenesis of both gonads
and adrenal glands (Kreidberg et al., 1993; Luo et al., 1994;
Moore et al., 1999). Whereas both WT1 and SF1 are expressed
in the AGP, WT1 is switched off within the adrenal primordium
soon after separation (Moore et al., 1998; Vidal and Schedl,
2000). The functional significance of this repression is presently
unknown.velopmental Cell 27, 5–18, October 14, 2013 ª2013 Elsevier Inc. 5
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WT1 Marks Steroidogenic Progenitors in Adult LifeIn the present study, we identify WT1 as an essential player in
defining AGP cell identity. We show that ectopic expression of
the transcriptionally active WT1 KTS isoform is sufficient to
prevent differentiation of AGP cells into steroidogenic cells by
directly regulating the expression of genes such as Gli1 and
Tcf21. In addition, we identify AGP-like cells within the adrenal
cortex that exhibit WT1 expression and maintain the ability to
generate both adrenocortical and gonadal steroidogenic cells
throughout life.
RESULTS
WT1 Repression Is Essential for Adrenocortical
Development
To study the dynamics of WT1 expression in adrenal develop-
ment, we first carried out comparative expression analysis at
various developmental stages. At E9.5, WT1 expression was
found throughout the urogenital ridge, where it largely overlap-
ped with GATA4 (Figure 1A). Appearance of first SF1 positive
(WT1+/GATA4+/SF1+) cells occurred at E9.75 (Figure 1A) and
was followed by rapid downregulation of WT1 and GATA4 in
the presumptive adrenal progenitor compartment (Figure 1B).
By E11.5, WT1 was no longer detectable in the majority of
SF1+ adrenocortical progenitors (Figure 1B). Of note, rare
WT1+/GATA4+ cells, some of which expressed SF1, persisted
within the adrenal cortex throughout development (Figure 1B, ar-
rows; Figure S1C available online). In contrast to the adrenal
gland, cells within the developing gonad continued to coexpress
WT1 and SF1 until later stages (Figure 1C and data not shown).
To understand the functional significance of Wt1 repression
during adrenocortical differentiation, we generated mice that
permit Cre-mediated activation of WT1 + or KTS isoforms in
a tissue-specific fashion (Rosa26:Wt1+KTS and Rosa26:
Wt1KTS lines; Figures S1A and S1B). Genetic crosses with
the SF1:Crehigh line (Bingham et al., 2006), a transgenic line
expressing high levels of Cre within the steroidogenic
compartment, resulted in activation of WT1 in the developing
adrenal cortex as early as E12.5 (Figure S1C). Heterozygous
Rosa26+/Wt1+KTS; Sf1:Cre and Rosa26+/Wt1KTS; Sf1:Cre
embryos developed normal adrenal glands (data not shown).
Because Rosa26 is known to be a relatively weak promoter,
we crossed the targeted allele to the homozygous state to
further increase transgene expression levels. Homozygous
Rosa26Wt1+KTS/Wt1+KTS; Sf1:Cre embryos (from now on called
+KTSGOF) displayed no dramatic changes in adrenal architecture
(Figure 1E). In contrast, Rosa26Wt1KTS/Wt1KTS; Sf1:Cre mice
(from now on called KTSGOF) developed highly abnormal adre-
nal glands of reduced size and abnormal cellular morphology
(Figures 1E and S1C–S1E).
To determine if WT1 repression was necessary for differentia-
tion of progenitors into adrenocortical cells, we examined
whether the expression of the AGP marker gene GATA4 per-
sisted in transgenic animals. Indeed, activation of WT1KTS,
but not WT1+KTS, triggered expression of GATA4 in SF1-
expressing cells (Figure 1E). Expression of GATA4 was evident
as early as E12.5 (Figure S1C). At this early time point, both
GATA4 andWT1were expressed homogenously in all fetal adre-
nocortical (SF1+) cells of KTSGOF mice (Figure S1C). Later in
development, two subtypes of cells became apparent that6 Developmental Cell 27, 5–18, October 14, 2013 ª2013 Elsevier Incwere distinguished by the levels of WT1 expression, perhaps
as a result of stochastic/epigenetic factors. WT1high cells (high
levels of WT1) showed ectopic activation of GATA4, but
exhibited low levels of SF1 (Figure 1E, KTSGOF, and S1C). In
contrast, WT1low cells maintained strong SF1 expression and
showed reduced levels of GATA4. We conclude that high levels
of WT1-KTS prevent complete differentiation of AGP cells into
steroidogenic adrenocortical cells.
Compensation of Hormonal Production in Adult WT1-
KTS-Expressing Adrenal Glands
Adrenal glands from adult KTSGOF animals were smaller than
controls (Table S1) and displayed cortical spindle-shaped cells,
effectively dividing the cortex into lobular structures (Figure 2A).
In each lobule, the zonation of the gland was grossly conserved,
as indicated by the expression of the general steroidogenic
enzyme 3b-HSD2, and the zona fasciculatamarker AKR1b7 (Fig-
ure S2A). The only affected adrenocortical area was the X-zone,
which was dramatically reduced in KTSGOF mice (Figure S2B).
Despite the severe morphological changes, the adrenal glands
fromKTSGOF animals appeared to be functional and transgenic
animals showed normal circulating levels of corticosterone (Fig-
ure S2C). Expression levels of the main enzymes involved in ste-
roidogenesis were also comparable to those found in control
animals (Figure S2E). Maintenance of steroid production was
likely achieved through increased ACTH levels in KTSGOF
mice (Figure S2C). ACTH is known to stimulate the expression
of steroidogenic enzymes, and indeed increased cellular staining
for AKR1b7 and 3b-HSD2 (Figure S2A) and 21-hydroxylase could
be observed (Figure S1E) together with a mild increase in ste-
roidogenic cell size (Figure S2D).
Immunostaining analysis revealed a similar association as
observed during development, and steroidogenic SF1-positive
cells expressed only very low levels of WT1 (Figure 2B). In
contrast, cortical spindle-shaped cells in adultKTSGOF animals
showed strong expression of WT1 and reduced SF1 (Figure 2B).
Surprisingly, we also occasionally observed spindle-shaped
WT1+; SF1low cells in the adrenal cortex of wild-type animals,
but in contrast toKTSGOFmice these were found in rare wedge
shape patches located in the subcapsular region (Figure 2C). +
KTSGOF animals did not show a dramatic phenotype (Figure 2A)
and, although low expression of WT1 was present in steroido-
genic cells, only a few spindle-shaped WT1+ cells could be
detected and these were restricted to the subcapsular region
(Figure 2B).
–KTSGOF Animals Develop Normal Gonads and Are
Fertile
The Sf1:Cre driver is not only expressed in adrenocortical, but
also in gonadal cells (Bingham et al., 2006), and we wondered
whether gonads may also be affected in this transgenic strain.
In males, gonadal steroid synthesis is initiated during develop-
ment, whereas females only produce sex hormones after birth.
The expression pattern p450scc, a functional marker of steroido-
genic cells, was unchanged between wild-type and KTSGOF
embryos (Figure S2F), suggesting that ectopic expression of
WT1 did not interfere with steroid synthesis during development.
ISH analysis for 21-hydroxylase did not reveal abnormal
displacement of adrenocortical cells into the gonads ofKTSGOF.
Figure 1. Repression of WT1 Is Required to Allow Adrenocortical Differentiation
(A) Immunostaining againstWT1 (green), SF1 (red), andGATA4 (blue) in early (E9.5) and late (E9.75) AGP.WT1 andGATA4 characterize AGP cells from the earliest
stages, whereas SF1 can only be detected in late AGP cells.
(B) WT1+ cells (green) are detected in the mesenchyme surrounding the adrenal primordium before encapsulation (E11.5 and E12.5) and in the adrenal capsule at
later developmental stages. Few WT1+, SF1 cells are also located within the adrenal cortex after encapsulation (arrow).
(C) Coexpression of WT1 and SF1 persists in E11.5 and E12.5 gonads until later stages.
(D) Schematic representation of the genetic approach used to ectopically express WT1KTS isoforms in steroidogenic cells. Black arrowheads indicate LoxP
sites. An equivalent strategy was used to knock in and ectopically express Wt1+KTS isoforms.
(E)WT1 (blue) SF1 (red) andGATA4 (green) immunofluorescence on adrenal sections fromCTR,KTSGOF and +KTSGOFE15.5 embryos. Two cell populations can
be distinguished in KTSGOF adrenal cortex (insets): WT1high, which have strong GATA4 and low SF1 expression (arrows); and WT1low, which instead have
reduced or absent GATA4 and strong SF1 expression (arrowheads). Please note that the cytoplasmic WT1 staining in control adrenal glands represents
background noise.
me, mesonephros; ce, coelomic epithelium; and ap, adrenal primordium. See also Figure S1.
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Figure 2. Cells Ectopically Expressing WT1-KTS Are Blocked in an AGP-like State throughout Life
(A) Haematoxylin and eosin staining of adrenals from wild-type,KTSGOF and + KTSGOF adult mice. Arrows indicate capsular-like cells within the adrenal cortex
of KTSGOF animals.
(B) Immunostaining against WT1 (red) and SF1 (green) on adrenals from wild-type,KTSGOF and +KTSGOF adult mice shows the persistence of WT1+ expressing
cells within the adrenal cortex of KTSGOF and +KTSGOF mice.
(C) Immunostaining for WT1 (green) and SF1 (red) on adult adrenal glands reveals the presence of WT1+ cells within the adrenal capsule (left) and in rare patches
located in the subcapsular cortex (asterisk, right).
(D) WT1 positive capsular and cortical cells (red) found in adult wild-type animals also express GATA4 (green). Note the cytoplasmic GATA4 signal in
steroidogenic cells represents background (asterisk).
(E) RT-qPCR on adrenal glands from E14.5 embryos and adult mice. Quantification of Wt1 and Gata4 messenger RNAs reveals increased expression of both
genes inKTSGOF adrenals. E 14.5:Wt1,CTR: 100 ± 61.85, n = 6;KTSGOF: 522.28 ± 89.27, n = 6;Gata4, CTR: 100 ± 35.38, n = 6;KTSGOF: 407.20 ± 109.67, n =
6. Adult:Wt1, CTR: 100 ± 48.20, n = 9; KTSGOF: 10,578.96 ± 12,509.51, n = 3; Gata4, CTR: 100 ± 69.51, n = 6; KTSGOF: 569.70 ± 309.06, n = 4. ***p < 0.001.
Statistical significance was determined using Student’s t test. Mean values ± SEM. The data presented were normalized for Hprt1 expression.
Ca, adrenal capsule; Co, adrenal cortex; and m, adrenal medulla. See also Figure S2.
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ure S2G), as has been described in wild-type testes (Val et al.,
2006). Finally, gonads from adult KTSGOF animals displayed
normal histology (Figures S2H and S2I) and both sexes were
fertile. qPCR analysis for WT1 revealed only very mild overex-
pression of Wt1-KTS in the developing gonads (Figure S2J),
which may explain the lack of a gonadal phenotype.
WT1 Activates Tcf21 and Gli1
Given the similar morphology of WT1-expressing cells in
KTSGOF animals and those discovered in control animals (Fig-
ure 2C), we next asked whether they shared expression of com-
mon AGP markers. We first investigated the expression of the
transcription factor GATA4 that we found coexpressed with
WT1 in AGP cells, in a proportion of capsular and in few cortical
cells in the developing adrenals (Figures 1A, 1E, and S1C).
Indeed, GATA4 was expressed in both WT1+ capsular cells
and spindle-shaped cells within the adult adrenal cortex in
both wild-type and KTSGOF animals (Figure 2D). RT-qPCR
analysis further confirmed the association of WT1 and GATA4
expression and the expression of both genes was strongly
increased in KTSGOF animals (Figure 2E).
Gli1 and Tcf21 encode two transcription factors expressed in
capsular cells that have been recently suggested to mark adre-
nal progenitor cells (Huang et al., 2010; King et al., 2009; Kim
and Hammer, 2007). To examine whether WT1 overlaps with
the expression of these markers we performed staining against
b-galactosidase in Gli1:LacZ mice (Bai et al., 2002) and RNA
in situ hybridization for the Tcf21 transcript. Indeed, expression
of both genes largely followed WT1 expression in cortical and
capsular cells in wild-type animals (Figures 3A–3C and 3F), albeit
a proportion of GLI1-expressing cells, primarily located at the
interior side of the capsule, were negative for WT1 (Figure 3A,
asterisk). To test whether WT1 induces expression of Tcf21
and Gli1, we next performed RT-qPCR analysis. Both Tcf21
and Gli1 transcripts were dramatically increased in KTSGOF
adrenals (Figures 3D and 3E) and their expression was restricted
to spindle-shaped WT1+ cells (Figure 3F). Similarly, Ptch1, a
downstream target of GLI1, was increased in KTSGOF, but
not in +KTSGOF animals (Figures S3A and S3B). In contrast,
expression of Shh, a gene marking a population of subcapsular
cells in wild-type animals (King et al., 2009; Huang et al., 2010),
showed no significant change, although Shh-expressing cells
were misplaced in KTSGOF mice (Figures S3A and S3B).
Because WT1-KTS acts as a transcriptional regulator, we
next asked whether it might directly activate the promoters of
Gata4, Tcf21, and Gli1. Primers were designed according to
the presence of evolutionary conserved regions and peaks
identified in WT1 ChIP-seq analysis carried out on E18.5 kid-
neys (Figures S3C–S3E). In vivo ChIP assays performed on
adrenal glands from KTSGOF animals (Figure 3G) demon-
strated WT1 binding to two evolutionary conserved regions
upstream from Tcf21 (1.5 and 48.5 kb from the transcription
start site) and an intronic region of Gli1 (Figure 3G). We were un-
able to detect any enriched region in the promoter of Gata4
(data not shown).
Taken together, these data indicate that ectopic expression of
the transcriptionally active isoform of WT1 (WT1KTS), but not
WT1+KTS, in adrenal primordial cells is sufficient to preventDeAGP cells from differentiation in a process that is likely to involve
the WT1 target genes Gli1 and Tcf21.
WT1+ Progenitors Generate Adrenocortical Cells during
Development
To better understand the relationship between WT1-expressing
cells and their descendants, we next carried out cell-lineage
tracing experiments using Wt1:Cre-GFP; mTmG mice (Zhou
et al., 2008). Cre-induced recombination activates the green
fluorescent protein and thus irreversibly labels all Wt1-express-
ing cells as well as their descendants. Consistent with a direct
descendance of steroidogenic cells from WT1+ AGP cells (Fig-
ure 1A), the totality of the SF1+ adrenal cortical cells stained pos-
itive for GFP (Figure S4A). To address whether WT1-expressing
mesenchymal cells maintain progenitor features at later stages
of development, we resorted to the recently generated
Wt1:Cre-ERT2 strain, which allows temporal control of Cre activ-
ity (Zhou et al., 2008; Figure 4A). Activation of Cre recombinase
by tamoxifen injection at E12.5 or E14.5 resulted in labeling of a
large proportion of cells within the adrenal capsule at E18.5 (Fig-
ures 4B and 4D), indicating that WT1+ mesenchymal cells
directly participate in the generation of this tissue. Moreover, a
small proportion of GFP cells was located within the adrenal
cortex and some of them expressed the steroidogenic marker
SF1 (Figure 4B). Importantly, these GFP+SF1+ cells had lost
WT1, indicating a complete differentiation of WT1+ progenitors
into adrenocortical cells (Figures 4B and S4B).
Recently King and colleagues (King et al., 2009) described a
progenitor cell population residing within the adrenal capsule
that expresses the transcription factor GLI1. Given the fact that
we identified Gli1 as a direct target of WT1, we decided to inves-
tigate the relationship between these two populations. Analysis
of Wt1:Cre-ERT2; mTmG; Gli1:LacZ E18.5 embryos treated
with tamoxifen at E12.5 allowed us to highlight a partial overlap
of expression between the two factors (Figures S4E and S4F).
Nevertheless, lineage tracing of WT1-expressing cells resulted
in a substantially different pattern when compared to that
obtained with Gli1:Cre-ERT2 mice (King et al., 2009). GFP was
mainly detected in the external capsule, where WT1 expression
is stronger, and did not cover the entire GLI1 population (Figures
S4E and S4F).
From our data, it appears that the activation of the Wt1:Cre-
ERT2 only occurs in a subpopulation of cells expressing WT1
(and thus Cre-ERT2) at high levels (Figure S4E). Cells traced by
King and colleagues are likely to beWT1low orWT1-negative pre-
cursors that may have arisen from AGP cells at an early time
point of development. Indeed, we could identify WT1GLI1+
cells at the interior side of the capsule, which seem to be good
candidates for such a population (Figure S4E, asterisk).
WT1+ Cells Are Long-Living Progenitors Able to
Generate Adrenocortical Cells throughout Life
Given the persistence of rare WT1+ cells in adult adrenal glands
(Figure 2C), we next examinedwhether theymight retain progen-
itor properties throughout life. Tamoxifen induction at E12.5 or
E14.5 revealed GFP-labeled cells within the capsule (Figures
4B and 4D; E18.5), as well as a small number of GFP patches
within the cortex at E18.5 (Figures 4B and S4B–S4D). The num-
ber (Figure S4G) and size of cortical patches of GFP+ cellsvelopmental Cell 27, 5–18, October 14, 2013 ª2013 Elsevier Inc. 9
Figure 3. WT1-KTS Ectopic Expression Directly Upregulates Tcf21 and Gli1
(A and B) LacZ (green) and WT1 (red) immunofluorescence on adrenal sections from adult Gli1:LacZmice. (A) The adrenal capsule is composed of at least three
cells types that can be distinguished by the presence or absence of WT1 and GLI1 (WT1+ GLI1, arrowhead; WT1GLI1+ asterisk; WT1+ GLI1+, arrows in insets).
(B) WT1+ adrenocortical patches are also positive for GLI1 expression.
(C) Tcf21 RNA in situ hybridization showing expression of this marker in the same cells.
(D and E) RT-qPCR showing increased Tcf21 (D) and Gli1 (E) expression in adrenal glands of E14.5 embryos or adult KTSGOF mice. E14.5: Tcf21, CTR: 100 ±
33.29, n = 4;KTSGOF: 461.52 ± 102.07, n = 6;Gli1, CTR: 100 ± 42.58, n = 4;KTSGOF: 317.34 ± 63.02, n = 6. Adult: Tcf21 CTR: 100 ± 110.91, n = 20;KTSGOF:
298.77 ± 123.12, n = 8;Gli1, CTR: 100 ± 147.46, n = 10;KTSGOF: 334.15 ± 305.52, n = 4. ***p < 0.001, *p < 0.05 Statistical significance was determined using the
Student’s t test. Mean values ± SEM. The data presented were normalized for Hprt1 expression.
(F)WT1 (red)andSF1 (green) immunofluorescenceonconsecutivesections toTcf21 (left)orGli1 (right)RNA insituhybridizationonE18.5adrenalglands,showsoverlap
between WT1 and the RNA for the two markers in both CTR and KTSGOF. Please note that the cytoplasmic WT1 staining in control adrenal glands is background.
(G) ChIP analysis on KTSGOF adrenal glands shows binding of WT1-KTS to the proximal promoter of Tcf21 and to an intronic region of Gli1. A region
located 2.7kb upstream of Tcf21 with background amplification is shown as a negative control.
Ca, adrenal capsule; and Co, adrenal cortex. See also Figure S3.
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Figure 4. WT1-Expressing Cells Are Progenitors Able to Differentiate into Steroidogenic Cells
(A) Schematic representation of the cell lineage tracing experiments performed on Wt1:Cre-ERT2; mTmG mice or embryos indicating the time point when
tamoxifen was administered.
(B–F) WT1 or DNA (blue), SF1, 3bHSD2, or AKR1b7 (red) and GFP (green) immunofluorescence on samples of adrenal glands fromWt1:Cre-ERT2; mTmGmice of
different ages treated with tamoxifen at E12.5 (B and C) or E14.5 (D–F). During development, the majority of GFP+ cells are localized within the capsule (B and D,
E18.5). Postnatal patches of WT1+, GFP+ cells expand under the adrenal capsule and few cells acquire a steroidogenic phenotype.
Co, adrenal cortex; Ca, adrenal capsule; and m, adrenal medulla. See also Figure S4.
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Figure 5. WT1+ Cells Maintain the Ability to Generate Subcapsular Patches and to Differentiate into Steroidogenic Cells throughout Life
(A–D) Immunostaining against WT1 (blue), SF1 (red), and GFP (green) on adrenal glands fromWt1:Cre-ERT2; mTmGmice treated with four consecutive doses of
tamoxifen between 10 and 12weeks of age and collected after 10 days (A), 1month (B), and 7months (C and D) after the last administration. Almost all GFP+ cells
also expressWT1 and SF1 (A–C). GFP+ SF1+WT1 cells can be detected in a subset of patches (B andC). GFP+WT1+ SF1 capsular cells can be detected within
the adrenal capsule up to 7 months after force-feeding (D).
(legend continued on next page)
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shaped patches spanning the entire adrenal cortex (Figures 4C
and 4F). Interestingly, a small proportion of cells, generally
located at the tips of the wedges, lost WT1 and acquired ste-
roidogenic features, as evidenced by the expression of high
levels of SF1, AKR1b7, and 3bHSD2 (Figures 4C, 4E, and 4F).
To further investigate the role of WT1+ cells in adrenal homeo-
stasis, we performed time course experiments in adult animals
(tamoxifen induction at 3 or 10–12 weeks of age; Figure 4A).
GFP+ cells were detected in the subcapsular region as early as
3 days after tamoxifen induction. Over time, patches significantly
increased in size (Figures 5A–5C) and number (Figures 5E and
5F), although they remained a small proportion of the adrenal
cortex in all samples analyzed. Staining for the endothelial
marker PECAM did not reveal an overlap with GFP-positive cells
(Figures S5C and S5D), suggesting that WT1+ progenitors do not
give rise to endothelial cells within the adrenal. Instead, we
observed a small proportion of GFP+ cells that lost WT1 expres-
sion and acquired the morphology of differentiated steroido-
genic cells and strong SF1 staining (Figures 5B and 5C,
arrowheads).
Thus, WT1+ cells in adult adrenals represent a progenitor cell
population able to differentiate into adrenocortical steroidogenic
cells throughout life. Interestingly, GFP-positive cells that re-
tained WT1 expression could be identified within the adrenal
capsule as late as 7 months after tamoxifen injection (Figure 5D),
suggesting that they represent a long-lived cell population.
WT1+ Cells Generate Gonadal-like Cells within the
Adrenal Cortex upon Gonadectomy
WT1+ adrenocortical and AGP cells appear to share a significant
number of features and we wondered whether they might have
retained gonadal potential in the adrenal gland throughout life.
Gonadectomy has been shown to increase the appearance of
subcapsular spindle-shaped cells (called ‘‘A cells’’) and to pro-
mote their differentiation into gonadal-like cells (called ‘‘B cells’’)
capable of sex hormone synthesis (Bielinska et al., 2003; Wool-
ley et al., 1952, 1953), as a consequence of the increase in go-
nadotropins (Bielinska et al., 2005; Kero et al., 2000).
To address whether WT1+ cells can differentiate into gonadal
steroidogenic cells, we subjected adult male and female mice
(Wt1-CreERT2; mTmG) to gonadectomy shortly after mTmG
activation (Figure 6A). Strikingly, 10 weeks after gonadectomy,
we observed a dramatic expansion of GFP+ cells invading the
adrenal cortex (Figure 6B). Quantification also showed a rapid
increase in the number of GFP+ patches as early as 7 days after
gonadectomy in males (Figures S6C and S6D). In nongonadec-
tomized mice, the majority of GFP+ cells are incapable of ste-
roidogenesis (Figures 4 and 5), as evidenced by the absence
of the steroidogenic enzymes p450scc and 21-hydroxylase (Fig-
ures S5A and S5B). In contrast, the majority of GFP+ cells in
gonadectomized mice had lost WT1 expression and showed
high levels of SF1 (Figure 6C) and GATA4 (Figure S6A). More-(E and F) Quantification of the number of GFP+ patches within the adrenal cor
11.5 weeks (F) of age. The number of GFP+ clusters increases significantly from 3.
3 weeks of age, respectively. No significant increase in the number of GFP+ clus
5.75 ± 1.98 (N = 8). *p < 0.05. Statistical significance was determined using the S
Co, adrenal cortex; and Ca, adrenal capsule. See also Figure S5.
Devover, GFP+ cells expressed the general (both adrenal and gonad)
steroidogenic marker p450scc (Figure 6D), indicating that a
massive process of differentiation had taken place. Interestingly,
the same cells lacked the adrenocortical marker 21-hydroxylase
(Figure 6D), but expressed the gonadal-specific genes CYP17
and Lhr (Figures 6E–6G). Importantly, no CYP17 and Lhr staining
was found in sections from nongonadectomized control animals
(Figures 6E and 6F), indicating that gonadectomy oriented these
GFP+ cells toward a gonadal steroidogenic fate.
Thus, WT1+ cells are able to respond to hormonal changes
following gonadectomy by differentiating into sex hormone-
producing ‘‘B cells’’ (Bielinska et al., 2005; Kero et al., 2000).
More generally, our results suggest that WT1+ cells represent
a progenitor population that maintains AGP-like features
throughout life and as such have the ability to differentiate into
steroidogenic cells of either adrenal or gonadal lineages.
DISCUSSION
High Levels of WT1 Expression Are Incompatible with
Differentiation into Steroidogenic Cells
The central role of WT1 in adrenogonadal development has been
established by a series of loss-of-function studies and is well
documented in the literature (Kreidberg et al., 1993; Moore
et al., 1999). Prior to activation of SF1 (E9.5), early AGP precur-
sors express both WT1 and GATA4 (Figure 1A). WT1 plays a
major role in this tissue by directly regulating expression of the
steroidogenic factor Sf1 (Wilhelm and Englert, 2002) probably
through association with CITED2 (Val et al., 2007). After separa-
tion, and upon activation of Sf1, adrenocortical cells lose WT1
before they differentiate into true steroidogenic cells.
Our gain-of-function analysis lends further support to the
hypothesis that WT1 needs to be repressed for steroidogenesis
to occur. Indeed, ectopic expression of high levels of WT1 effec-
tively blocked the differentiation process. Interestingly, while all
adrenal progenitor cells in KTSGOF mice express WT1, two
different types of cells that differ in WT1 expression levels could
be distinguished. Although themolecular reason for this differen-
tial expression is presently unclear and may involve stochastic
events, the outcome is highly instructive: while WT1low cells
develop adrenocortical features including high levels of SF1
and fully differentiate into steroidogenic cells, WT1 expression
in WT1high cells has crossed a certain threshold and as a conse-
quence, these cells express GATA4, Gli1, and Tcf21; have low
levels of SF1; and fail to differentiate. This results in a composite
organ containing adrenal steroidogenic cells and undifferenti-
ated adreno-gonadal precursors.
On the molecular level, our data reveal a direct regulation of
Gli1 and Tcf21 by WT1, two genes that are upregulated in
AGP-like cells in KTSGOF animals. The finding that TCF21 can
bind and inhibit the SF1 promoter (Franc¸a et al., 2013; Tamura
et al., 2001) provides a molecular explanation for the observed
SF1 repression, although we cannot exclude that additional,tex of Wt1:Cre-ERT2; mTmG mice treated with tamoxifen at 3 weeks (E) or
56 ± 2.70 (N = 9) to 6.00 ± 2.35 (N = 9), 3 days and 9 weeks after force-feeding at
ters is detected in animals force-fed at 11.5 weeks, from 3.38 ± 2.00 (N = 8) to
tudent’s t test. Mean values ± SEM.
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Figure 6. WT1+ Cells Generate Cells with Gonadal Characteristics in the Adrenal Cortex upon Gonadectomy
(A) Schematic representation of the experimental design.
(B–G) Adrenal glands frommice sacrificed 10 weeks after gonadectomy, or nongonadectomized control. Gonadectomy induces massive invasion of the adrenal
cortex by GFP+ cells, derived fromWT1+ cells (B). Higher magnification shows that the majority of GFP+ cells have lost WT1 expression, whereas SF1 is present
(C). (D) RNA in situ hybridization shows that cells expressing cytochromeP450scc do not express the adrenocortical-specificmarker 21-hydroxylase. Please note
that the three stainings in (C) and (D) were performed on consecutive sections, thus representing the same area. (E) CYP17 (red), a marker of cells producing sex
hormones (gonadal cells) appears in some cells within the adrenal cortex of gonadectomized mice, but is never found in control animals. Coexpression of CYP17
and GFP in the same cells indicates that they are directly derived fromWT1-expressing cells. (F and G) LH receptorRNA in situ hybridization shows expression of
this gene in gonadectomized animals (F), where it colocalizes with GFP+ cells (G).
Co, adrenal cortex; Ca, adrenal capsule; and m, adrenal medulla. See also Figure S6.
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Figure 7. Schematic Representation of the Fate ofWT1+ Progenitors
during Development and Adulthood
Our data expose clear parallels between mechanisms that drive adrenogo-
nadal development and the differentiation of AGP-like cells in the adult adrenal
cortex. Progenitor cells are characterized by WT1 and GATA4 expression.
WT1 prevents differentiation by regulating expression of key genes such as
GLI1 and TCF21. Suppression of WT1 is thus a key step to allow steroidogenic
differentiation both during development and or adult AGP-like cells. Upon
gonadectomy, AGP-like cells respond by differentiating into gonadal ste-
roidogenic cells.
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observed phenotype. Consequently, WT1 appears to have a
dual function in the development of the adrenal cortex. First, it
is required for the activation of Sf1 thus determining the steroido-
genic primordium. At the same time it limits the amount of Sf1
expression via the activation of Tcf21, thus effectively inhibiting
full-blown differentiation toward the steroidogenic lineage (Fig-
ure 7). This second process probably occurs in a population of
cells, which will give rise to the adrenal capsule. Thus, WT1
acts as a molecular switch between steroidogenic or capsular
identity playing a major role in regulating organ homeostasis.
In gonads, coexpression of WT1 and intermediate levels of
SF1 persist within Sertoli cells until later stages, where they
contribute to the expression of the nonsteroidogenic hormone
AMH (Nachtigal et al., 1998). Remarkably, also in gonads ste-
roidogenesis is restricted to cells that lose WT1 expression
and show high levels of SF1: the Leydig cells in testes and theca
cells in ovaries (Morohashi and Omura, 1996). We therefore
hypothesize that high levels of WT1 are more generally incom-
patible with the steroidogenic program. Consistent with this
notion, induced deletion of Wt1 in Sertoli cells leads to an in-
crease in the number of steroidogenic (Leydig) cells (Gao et al.,
2006), possibly by trans-differentiation. KTSGOF mice do not
show a gonadal phenotype, but the levels of WT1 expression
from the Rosa26 promoter appear to be extremely low. Further
studies with stronger promoters would be needed to evaluate
the effect of WT1 overexpression in gonadal steroidogenic cells.
WT1 Marks a Progenitor Cell Population within the
Adrenal Gland
After separation from the AGP, adrenal development proceeds
through a series of well-defined steps: (1) invasion of the adrenal
primordium by chromaffin cells that will eventually form the adre-Devnal medulla (Anderson and Axel, 1986); (2) encapsulation of the
adrenal primordium (Mesiano and Jaffe, 1997; Uotila, 1940);
and (3) development of the definitive cortex (Zubair et al.,
2008). Our cell lineage tracing experiments provide direct evi-
dence for a mesenchymal origin of the adrenal capsule. In
Wt1:Cre-ERT2; mTmG embryos that were induced at E11.5
and E12.5—a time point when WT1 is absent from the adrenal
cortex, but expressed within mesenchymal cells surrounding
the forming adrenal gland—the majority of capsular cells were
found to be GFP positive. These data indicate that a significant
proportion of cells of the adrenal capsule are derived from
condensing WT1+ mesenchymal precursors.
The lineage tracing experiments carried out in this study also
allows us to draw important conclusions regarding the formation
of the steroidogenic lineage. Using the constitutiveWt1:Cre line,
all steroidogenic cells were GFP positive, indicating that an early
progenitor population—the AGP—must have expressedWT1. In
contrast, activation of WT1:Cre-ERT2 at later stages (E11.5 and
onward) did not result in a significant number of labeled steroido-
genic cells, suggesting that these cells are derived from a popu-
lation of progenitors that has lost WT1 expression. The recently
identified GLI1+ cell population (King et al., 2009, Huang et al.,
2010) is likely to fulfill this role. Our immunofluorescent analysis
identified four cell populations defined by the expression pattern
of WT1 and GLI1 in the developing adrenal (Figures S4E and
S4F): WT1+ GLI1+ capsular, WT1+ GLI1 capsular, WT1+
GLI1 cortical, andWT1GLI1+ capsular cells. We thus propose
that this last population constitutes the main steroidogenic pro-
genitors that give rise to the definitive cortex.
While not themajor source of steroidogenic cells during devel-
opment, WT1+ adrenal cells maintain the ability to differentiate
into steroidogenic cells throughout life. Interestingly, the number
of cortical GFP+ patches in Wt1:Cre-ERT2; mTmG mice in-
creases over time. Whereas early on patches are probably
generated by expansion of WT1+ cells located within the cortex
at the time of activation, in adult life other progenitors must be
responsible for their generation. Three lines of evidence suggest
the adrenal capsule as a source of these cells: (1) the adrenal
capsule forms a rich reservoir of WT1+ cells; (2) capsular cells
share many of the properties of ‘‘A cells,’’ including the expres-
sion of WT1, GATA4, Tcf21, and Gli1; and (3) GFP+/WT1+
patches are always found in the subcapsular area and are in
direct contact with the capsule.
Invading Cells Maintain AGP-like Properties throughout
Life
Invasion of the subcapsular region by spindle-shaped cells (‘‘A
cells’’) is a frequent event in aged mice (Woolley et al., 1952,
1953). Our data identify WT1+ progenitors that are probably sit-
uated within the capsule, as the source of these cells. Interest-
ingly, AGP-like cells have the ability not only to differentiate
into adrenocortical, but also into gonadal steroidogenic lineages
upon gonadectomy. As such, they share features of adreno-
gonadal progenitors. Indeed, their molecular signature appears
to largely overlap with that of AGP cells as they express WT1,
GATA4, and SF1.
The process of differentiation of capsular cells into adrenocor-
tical or gonadal-like cells appears to recapitulate normal devel-
opment (Figure 7). WT1+ capsular cells coexpress GATA4,elopmental Cell 27, 5–18, October 14, 2013 ª2013 Elsevier Inc. 15
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During the process of differentiation into ‘‘A cells’’, low levels
of SF1 expression, a specific marker of the AGP, are acquired
(Figure 1A; E9.75; Hatano et al., 1996). The final step of differen-
tiation involves loss of WT1 and an increase of SF1 expression
that in turn activates the steroidogenic program.
‘‘A cells’’ are generated in control and gonadectomized mice.
In control mice, ‘‘A cells’’ remain quiescent and only very few
cells terminally differentiate into adrenocortical cells and express
the steroidogenic markers SF1, AKR1b7, and 3 beta HSD. In
contrast, gonadectomy induces proliferation and differentiation
of ‘‘A cells’’ toward the steroidogenic gonadal lineage, as
demonstrated by expression of CYP17 and the LH receptor. Dif-
ferentiation is likely to be a direct response to the increased
levels of luteinizing hormone (LH) that are induced after removal
of the gonads (Bielinska et al., 2003, 2005; Johnsen et al., 2006;
Kero et al., 2000). The increased production of ‘‘A cells’’ and their
differentiation into gonadal cells can therefore be interpreted as
an attempt of the mammalian body to balance hormone
homeostasis.
Interestingly, a similar mechanismmay be at work in gonads of
children that suffer from congenital adrenal hyperplasia. Lack of
glucocorticoid production in these patients disrupts the negative
feedback regulation of adrenocorticotropic hormone (ACTH)
secretion. The resulting high levels of ACTH induce so-called
adrenal rests within gonadal tissue that have features of adrenal
steroidogenic cells (Cabrera et al., 2001; Stikkelbroeck et al.,
2001). It is tempting to speculate that AGP-like cells also persist
in gonads that, upon hormonal challenge, can be activated to
differentiate into adrenal steroidogenic precursors. Alternatively,
these cells are derived from developmental progenitors as sug-
gested by Val et al., 2006.
Based on the above findings, we propose that WT1+ capsular
cells in the adrenal gland might represent a reserve stem/pro-
genitor cell population with adrenal progenitor features that is
mobilized only after severe loss of steroidogenic cells has
occurred. The fact that the mammalian body responds by
inducing differentiation of WT1+ progenitors into gonadal cells
at a heterotopic site (the adrenal gland) is an impressive feat
that exemplifies the remarkable adaptation of the mammalian
body to stress.
In conclusion, we identified WT1, and more specifically its
KTS isoforms, as an essential player in maintaining AGP cells
in the undifferentiated state. Although vital for adrenal and
gonadal development, its repression is a key step for differenti-
ation of adrenocortical steroidogenic cells. As a further demon-
stration of this, undifferentiated AGP-like cells that maintain
WT1 are found in the adrenal cortex throughout life, where they
maintain the ability to generate both steroidogenic cell types.EXPERIMENTAL PROCEDURES
Generation of the Rosa26:Wt1+ and –KTS Mice
Rosa26:Wt1KTS knockin mice were generated by homologous recombina-
tion in ES cells as previously described (Hammes et al., 2001). The cDNA
encoding WT1KTS was cloned into pENTR11 (Invitrogen) and introduced
into the Rosa26-DEST vector (Hohenstein et al., 2008), by in vitro recombina-
tion using the enzyme LR clonase II (Gateway Technology, Invitrogen). The
generated targeting vector was linearized with KpnI and electroporated into
129-derived murine ES cells. G-418 resistant clones were then screened16 Developmental Cell 27, 5–18, October 14, 2013 ª2013 Elsevier Inwith Southern blot using a 50 end probe and double-checked with a neomycin
probe.
Three positive clones for the construct were microinjected into C57BL6
blastocysts. Chimeric male founders were crossed with C57BL6 females to
achieve germ-line transmission of the targeted allele.
Mice
All animal work was conducted according to national and international guide-
lines. The Sf1:Cre; mTmG, Wt1:Cre-ERT2 and Gli1:LacZ mouse lines were
previously described (Bai et al., 2002; Bingham et al., 2006; Muzumdar
et al., 2007; Zhou et al., 2008). Cell lineage tracing experiments were carried
out by force-feeding themicewith 4mg of tamoxifen (Sigma-Aldrich) dissolved
in corn oil (Sigma-Aldrich), per 20 g of body weight. Cre activation during
development was obtained by a single tamoxifen administration into pregnant
females carrying either E 12.5 or E 14.5 embryos. Cre activation in adult mice
was obtained by administrating tamoxifen twice at 3 weeks (with 3-day inter-
vals) of age or twice a week for 2 weeks starting at 10 weeks of age.
Bilateral gonadectomy was performed on 3- and 12-week-old Wt1:Cre-
ERT2; mTmG animals 3 days after tamoxifen administration. Animals were
monitored until they fully recovered and were sacrificed at different time
points.
Quantification of GFP-Positive Patches
For quantification of the number of GFP+ patches, Wt1:Cre-ERT2; mTmG
animals were treated with a single dose of tamoxifen and sacrificed at different
time points. Both adrenal glands were fixed, cut, and every section was
stained with anti-GFP and WT1 antibodies. Quantification was performed by
microscope observation.
Immunofluorescence and Histological Analysis
For immunofluorescence experiments, tissues were fixed overnight in 4%
paraformaldehyde, progressively dehydrated, and paraffin-embedded. Then
7 mm thick sections were rehydrated, boiled in a pressure cooker for 2 min
with Antigen Unmasking Solution (Vector Laboratories), and blocked in a
PBS solution containing 10% normal donkey serum (Jackson Immunore-
search) and 3% BSA. All primary antibodies were applied overnight at 4C
at the concentration listed in the Supplemental Experimental Procedures. Sec-
ondary antibodieswere diluted 1:400 and applied at room temperature for 1 hr.
WT1was detected using a biotinylated secondary antibody, followed by strep-
tavidin-Cy3 conjugated (Sigma-Aldrich).
GFP immunohistochemistry after RNA in situ hybridization was performed
without antigen retrieval. The primary GFP antibody was detected with a
POD-conjugated secondary antibody. DAB staining was performed using
the Vector DAB substrate kit for peroxidise (cat. n. SK 4100) following manu-
facturer instructions.
For histological analysis, adrenal glands or gonads from embryos or adult
mice were fixed overnight in Bouin solution (Sigma Aldrich) or 4% para-
formaldehyde, were progressively dehydrated, and were embedded in
paraffin-embedding media. Then 7 mm thick sections were then stained with
hematoxylin and eosin.
RNA In Situ Hybridization
Tissues were fixed overnight in 4% paraformaldehyde, progressively dehy-
drated, and paraffin-embedded. Then 7 mm thick sections were hybridized
with Tcf21, Gli1, Ptch1, Shh, P450scc, 21-hydroxylase, or LH receptor probes
(details on request) according to previously described protocols (Comai et al.,
2010). The Tcf21 probewas PCR amplified from embryonic kidney cDNA using
the primers Tcf21 S and Tcf21 AS. The PCR fragment was cloned into the
pCRII vector (Invitrogen). The Lhr probe was PCR amplified from adult mouse
cDNA ovary using the primers LUPub Fr and LUPub Rev. pCR2.1 containing
theGli1 in situ probe was kindly provided byM. Studer (INSERMU636, Univer-
site´ de Nice-Sophia Antipolis).
RT-qPCR
RNA was extracted from E14.5 or adult adrenal glands using TRIzol reagent
(Invitrogen), following the manufacturer’s instructions. Reverse transcription
was performed using M-MLV reverse transcriptase (Invitrogen) in combination
with random primers. The cDNA obtained was then used as a template forc.
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WT1 Marks Steroidogenic Progenitors in Adult Lifequantitative PCR carried out using the TaqMan Master Kit (Roche) and a Light
Cycler 1.5 (Roche). Expression levels were normalized for Hprt1. Primers (see
primers list in the Supplemental Experimental Procedures) were designed on
Roche Universal ProbeLibrary website.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation assayswere conducted as described inWein-
mann and Farnham 2002, with minor modifications. Adrenal glands from
Rosa26Wt1KTS/Wt1KTS; Sf1:CRE adult mice were dissected and dissociated
in 20mMHEPES pH7.4, 1mMEDTA, 150mMNaCl, 1%SDS, 0.125Mglycine,
and 0.5 mg/ml phenylmethylsulfonyl fluoride (PMSF) and nuclei were released
by mechanical stress. Chromatin from nuclei was sheared by sonication to an
average of 400–600 bp in 20 mM HEPES pH 7.4, 1 mM EDTA, 150 mM NaCl,
0.4% SDS, and 0.5 mg/ml PMSF. Fifteen micrograms of antibody directed
against WT1 (C19, Santa Cruz) or Dicer (Santa Cruz) (used as a control) was
incubated with chromatin in 20 mM HEPES pH7.4, 1 mM EDTA, 150 mM
NaCl, 0.8% Triton X-100, 0.1% SDS, and 0.5 mg/ml PMSF. Controls included
a mock reaction consisting of a chromatin sample in buffer and with no anti-
body. Protein A Sepharose (Sigma) was used to precipitate chromatin IgG
complexes. Protein A was washed in series; three times with 20 mM HEPES
pH 7.4, 1 mM EDTA, 500 mM NaCl, 0.8% Triton X-100, 0.1% SDS, and
0.5 mg/ml PMSF; three times with 20 mM Tris pH 8.0, 1 mM EDTA, 250 mM
LiCl, 0.5% NP40, 0.5% deoxycholate, and 0.5 mg/ml PMSF; and twice in
20 mM Tris pH 8.0, 1 mM EDTA, and 0.5 mg/ml PMSF. Chromatin was eluted
with 50 mM NaHCO3 and 1% SDS. Protein-DNA crosslinks in chromatin were
reversed by heating at 65C for 6 hr, followed by phenol chloroform extraction
and ethanol precipitation. DNA was resuspended in 20 ml of water, and 0.5 ml
was used in each PCR reaction.
Hormone Measurements
Hormonemeasurements were performed as previously described (Sahut-Bar-
nola et al., 2010).
Cell Size Measurement
Cell size in wild-type and KTSGOF adrenal glands was measured using the
program ‘‘cell profiler’’ (BROAD Institute).
Statistical Analysis
Statistical analysis was performed according to the Student’s t test. Error
estimates values are expressed as SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.devcel.2013.09.003.
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